140 related articles for article (PubMed ID: 19224213)
1. Intrathoracic injection of paclitaxel for a patient with stage IV serous ovarian cancer: a case report.
Mitamura T; Hosaka M; Takeda M; Watari H; Sakuragi N
Cancer Chemother Pharmacol; 2009 Jun; 64(1):169-70. PubMed ID: 19224213
[TBL] [Abstract][Full Text] [Related]
2. Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis.
Lombardi G; Nicoletto MO; Gusella M; Fiduccia P; Dalla Palma M; Zuin A; Fiore D; Donach M; Zagonel V
Cancer Chemother Pharmacol; 2012 Mar; 69(3):781-7. PubMed ID: 22037881
[TBL] [Abstract][Full Text] [Related]
3. [A case of ovarian cancer stage IV and advanced rectal cancer responding to paclitaxel/carboplatin].
Kawaguchi R; Furukawa N; Morimoto Y; Ohi M; Osawa T; Koike H; Miyake T
Gan To Kagaku Ryoho; 2004 Apr; 31(4):619-22. PubMed ID: 15114712
[TBL] [Abstract][Full Text] [Related]
4. Management of malignant pleural effusion by multimodality treatment including the use of paclitaxel administered by 24-hour intrathoracic infusion for patients with carcinomatous pleuritis.
Ohta Y; Shimizu Y; Matsumoto I; Watanabe G
J Exp Clin Cancer Res; 2006 Mar; 25(1):15-9. PubMed ID: 16761613
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy with paclitaxel: a clinical and pharmacokinetic study.
de Bree E; Rosing H; Filis D; Romanos J; Melisssourgaki M; Daskalakis M; Pilatou M; Sanidas E; Taflampas P; Kalbakis K; Beijnen JH; Tsiftsis DD
Ann Surg Oncol; 2008 Apr; 15(4):1183-92. PubMed ID: 18239973
[TBL] [Abstract][Full Text] [Related]
6. Use of the collagen gel droplet embedded drug sensitivity test to determine drug sensitivity against ovarian mature cystic teratoma with malignant transformation to adenocarcinoma: a case report.
Yamagami W; Banno K; Kawaguchi M; Yanokura M; Kuwabara Y; Hirao N; Susumu N; Tsukazaki K; Aoki D
Chemotherapy; 2007; 53(2):137-41. PubMed ID: 17308380
[TBL] [Abstract][Full Text] [Related]
7. Complete response of a stage IV uterine papillary serous carcinoma to neoadjuvant chemotherapy with Taxol and carboplatin.
Le TD; Yamada SD; Rutgers JL; DiSaia PJ
Gynecol Oncol; 1999 Jun; 73(3):461-3. PubMed ID: 10366480
[TBL] [Abstract][Full Text] [Related]
8. Survival in women with ovarian cancer before and after the introduction of adjuvant paclitaxel; a 25-year, single institution review.
Shireen R; Brennan D; Flannelly G; Fennelly D; Lenehan P; Foley M
Ir Med J; 2012 Feb; 105(2):47-50. PubMed ID: 22455239
[TBL] [Abstract][Full Text] [Related]
9. Abraxane in the treatment of ovarian cancer: the absence of hypersensitivity reactions.
Micha JP; Goldstein BH; Birk CL; Rettenmaier MA; Brown JV
Gynecol Oncol; 2006 Feb; 100(2):437-8. PubMed ID: 16226797
[TBL] [Abstract][Full Text] [Related]
10. [Recurrent ovarian cancer with cancer peritonitis treated with weekly paclitaxel infusion--a clinicopharmacological study].
Urabe S; Fujiwara H; Egawa M; Fujitou N; Sakashita T; Date K; Mizunoe T; Ueda K; Urabe T
Gan To Kagaku Ryoho; 2004 Mar; 31(3):449-51. PubMed ID: 15045960
[TBL] [Abstract][Full Text] [Related]
11. Nonlinear pharmacokinetics of paclitaxel in ovarian cancer patients.
Ye M; Zhu Z; Fu Q; Shen K; Li DK
Acta Pharmacol Sin; 2000 Jul; 21(7):596-9. PubMed ID: 11360664
[TBL] [Abstract][Full Text] [Related]
12. Phase III trial of observation versus six courses of paclitaxel in patients with advanced epithelial ovarian cancer in complete response after six courses of paclitaxel/platinum-based chemotherapy: final results of the After-6 protocol 1.
Pecorelli S; Favalli G; Gadducci A; Katsaros D; Panici PB; Carpi A; Scambia G; Ballardini M; Nanni O; Conte P;
J Clin Oncol; 2009 Oct; 27(28):4642-8. PubMed ID: 19704064
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion (LDE) in patients with gynecologic cancers.
Dias ML; Carvalho JP; Rodrigues DG; Graziani SR; Maranhão RC
Cancer Chemother Pharmacol; 2007 Jan; 59(1):105-11. PubMed ID: 16699792
[TBL] [Abstract][Full Text] [Related]
14. Clindamycin-paclitaxel pharmacokinetic interaction in ovarian cancer patients.
Fruscio R; Lissoni AA; Frapolli R; Corso S; Mangioni C; D'Incalci M; Zucchetti M
Cancer Chemother Pharmacol; 2006 Sep; 58(3):319-25. PubMed ID: 16362296
[TBL] [Abstract][Full Text] [Related]
15. Primary central nervous system recurrence after paclitaxel therapy for epithelial ovarian malignancy.
Seewaldt VL; Figge DC; Greer BE; Tamimi HK; Brown WS; Cain JM
Gynecol Oncol; 1994 Dec; 55(3 Pt 1):456-8. PubMed ID: 7835788
[TBL] [Abstract][Full Text] [Related]
16. [Prolonged use of paclitaxel for platinum-refractory ovarian cancer--brief report].
Tanaka H; Konishi Y; Saito H
Gan To Kagaku Ryoho; 2001 Mar; 28(3):403-5. PubMed ID: 11265414
[TBL] [Abstract][Full Text] [Related]
17. Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma.
Safra T; Menczer J; Bernstein RM; Shpigel S; Matcejevsky D; Inbar MJ; Golan A; Grisaru D; Levy T
Gynecol Oncol; 2009 Aug; 114(2):215-8. PubMed ID: 19446318
[TBL] [Abstract][Full Text] [Related]
18. Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant.
Gershenson DM; Sun CC; Bodurka D; Coleman RL; Lu KH; Sood AK; Deavers M; Malpica AL; Kavanagh JJ
Gynecol Oncol; 2009 Jul; 114(1):48-52. PubMed ID: 19361839
[TBL] [Abstract][Full Text] [Related]
19. Different tissue distribution of paclitaxel with intravenous and intraperitoneal administration.
Soma D; Kitayama J; Ishigami H; Kaisaki S; Nagawa H
J Surg Res; 2009 Jul; 155(1):142-6. PubMed ID: 19328496
[TBL] [Abstract][Full Text] [Related]
20. Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxel.
Su D; Smith SM; Preti M; Schwartz P; Rutherford TJ; Menato G; Danese S; Ma S; Yu H; Katsaros D
Cancer; 2009 Jun; 115(11):2453-63. PubMed ID: 19322891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]